Published in World J Gastrointest Pharmacol Ther on August 06, 2012
Management of hepatocellular carcinoma: an update. Hepatology (2011) 33.57
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
Chronic hepatitis B: update 2009. Hepatology (2009) 16.08
Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology (2003) 10.11
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology (2000) 9.74
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology (2007) 9.44
EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol (2008) 9.14
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology (2010) 8.05
Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43
Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med (2008) 6.67
The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology (1990) 6.53
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology (2001) 6.19
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93
Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol (2010) 5.78
Diagnosis and management of autoimmune hepatitis. Hepatology (2010) 5.27
The survival benefit of liver transplantation. Am J Transplant (2005) 5.08
The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology (2002) 4.98
Hepatopulmonary syndrome--a liver-induced lung vascular disorder. N Engl J Med (2008) 4.71
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol (2010) 4.55
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology (1996) 4.54
Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med (1996) 4.10
Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology (1999) 3.99
Acute liver failure. N Engl J Med (1993) 3.81
Acute liver failure. Lancet (2010) 3.39
Diagnosis and treatment of autoimmune hepatitis. Hepatology (2002) 3.13
The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology (2003) 3.00
AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology (2005) 2.90
Survival benefit-based deceased-donor liver allocation. Am J Transplant (2009) 2.89
Results of the first year of the new liver allocation plan. Liver Transpl (2004) 2.86
Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J (2004) 2.80
Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi. N Engl J Med (1966) 2.65
Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology (2005) 2.63
Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology (1988) 2.60
Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology (2003) 2.56
Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology (2004) 2.49
The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant (2008) 2.48
Portopulmonary hypertension and hepatopulmonary syndrome. Lancet (2004) 2.48
Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl (2011) 2.40
Acute liver failure in the United States. Semin Liver Dis (2003) 2.39
Management of patients with cirrhosis awaiting liver transplantation. Gut (2010) 2.34
Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin. J Hepatol (2008) 2.33
Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol (2004) 2.28
Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B. Liver Transpl (2002) 2.25
The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology (1997) 2.14
Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation (2004) 2.13
Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg (2007) 2.12
Review article: the modern management of hepatic encephalopathy. Aliment Pharmacol Ther (2009) 2.09
MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut (2007) 2.09
Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl (2005) 2.06
Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl (2006) 2.02
Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transpl (2000) 1.96
Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology (2000) 1.96
Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol (1999) 1.92
Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl (2007) 1.91
Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology (2005) 1.89
Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer (2000) 1.82
Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology (2005) 1.82
Liver and intestine transplantation in the United States 1998-2007. Am J Transplant (2009) 1.73
Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology (1998) 1.69
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology (2005) 1.67
Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut (1999) 1.66
Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection. Hepatology (2011) 1.59
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis (2010) 1.54
Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: a systematic review. Liver Transpl (2002) 1.52
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology (1998) 1.48
Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C. Gastroenterology (2010) 1.47
Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol (2000) 1.39
Indications for liver transplantation. Gastroenterology (2008) 1.28
A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl (2003) 1.20
Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver Transpl (2012) 1.19
Liver transplantation in the United States from 1987-1998: updated results from the Pitt-UNOS Liver Transplant Registry. Clin Transpl (1998) 1.17
Alcohol use after liver transplantation in alcoholics: a clinical cohort follow-up study. Hepatology (1997) 1.16
Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients. Crit Care (2010) 1.14
Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc (1997) 1.12
Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis. Liver Transpl (2009) 1.10
Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl (2007) 1.10
Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective. Liver Transpl (2005) 1.10
Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management. Semin Liver Dis (1996) 1.09
Metabolic syndrome and liver transplantation: a review and guide to management. J Hepatol (2010) 1.08
[Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres]. Z Gastroenterol (2011) 1.07
Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. Hepatology (1999) 1.07
Nutritional support in patients with chronic liver disease. Nat Clin Pract Gastroenterol Hepatol (2006) 1.06
The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Hepatology (2000) 1.06
Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol (2010) 1.05
An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Liver Transpl (2000) 1.05
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease. Liver Transpl (2001) 1.05
Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome. Hepatology (2004) 1.04
Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology (1992) 1.03
Prevention of recurrent hepatitis B post-liver transplantation. Liver Transpl (2002) 1.02
Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs. Liver Transpl (2010) 0.98
Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology (1994) 0.98
Perioperative neurological complications after liver transplantation are best predicted by pre-transplant hepatic encephalopathy. Neurocrit Care (2008) 0.98
Recurrence of diseases following orthotopic liver transplantation. Am J Gastroenterol (2006) 0.98
Failure of customary treatment in chronic active liver disease: causes and management. Ann Clin Res (1976) 0.96
The place of downstaging for hepatocellular carcinoma. J Hepatol (2010) 0.95
Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant (2004) 0.94
The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol (2010) 0.94
Are patients with Child's A cirrhosis and hepatocellular carcinoma appropriate candidates for liver transplantation? Am J Transplant (2011) 0.93
Clinical characteristics and outcome of patients with cirrhosis and refractory ascites. Liver Int (2004) 0.93
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93
Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation. Liver Transpl (2013) 2.09
Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis. Radiology (2010) 1.97
Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology (2011) 1.94
PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals. Dig Liver Dis (2012) 1.70
Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C. Liver Transpl (2008) 1.65
Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus-infected liver tissue. Hepatology (2014) 1.58
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis (2010) 1.54
Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages. J Anat (2011) 1.51
Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine. Transplantation (2004) 1.49
Feasibility and limits of split liver transplantation from pediatric donors: an italian multicenter experience. Ann Surg (2006) 1.43
Nutritional status: its influence on the outcome of patients undergoing liver transplantation. Liver Int (2009) 1.23
Renal transplant in methylmalonic acidemia: could it be the best option? Report on a case at 10 years and review of the literature. Pediatr Nephrol (2007) 1.16
Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West. J Hepatol (2012) 1.14
Pregnancy after liver transplantation: report of 8 new cases and review of the literature. Transpl Immunol (2006) 1.01
Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again. Int J Hepatol (2012) 0.96
PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease. Dig Liver Dis (2013) 0.92
A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome. J Neurol Sci (2013) 0.91
Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT. Radiology (2009) 0.90
PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis. Liver Int (2013) 0.89
[Surgical management of schwannoma of biliary tract]. Chir Ital (2009) 0.89
Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system. Ther Apher Dial (2009) 0.88
Chronic kidney disease after liver transplantation: pretransplantation risk factors and predictors during follow-up. Transplantation (2013) 0.87
The bony labyrinth of Oreopithecus bambolii. J Hum Evol (2004) 0.85
Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging. Eur Radiol (2012) 0.85
Detection of hepatocellular carcinoma in patients with cirrhosis: added value of coronal reformations from isotropic voxels with 64-MDCT. AJR Am J Roentgenol (2009) 0.84
Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation. Clin Transplant (2011) 0.83
Treatment of recurrent hepatocellular carcinoma after liver transplantation. Liver Transpl (2011) 0.82
Preharvest donor hyperoxia predicts good early graft function and longer graft survival after liver transplantation. Liver Transpl (2005) 0.82
Acute hepatitis associated with lamotrigine and managed with the molecular adsorbents recirculating system (Mars). Epilepsia (2005) 0.82
MuRF-1 and p-GSK3β expression in muscle atrophy of cirrhosis. Liver Int (2013) 0.82
Gadobenate dimeglumine-enhanced magnetic resonance imaging of primary leiomyoma of the liver. J Magn Reson Imaging (2008) 0.82
Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it? Int J Biol Markers (2011) 0.81
Use of elderly donors for liver transplantation: has the limit been reached? J Gastrointestin Liver Dis (2011) 0.81
Inferior vena cava interruption in a liver transplantation deceased donor. Liver Int (2012) 0.81
Laparoscopy in Liver Transplantation: The Future has Arrived. HPB Surg (2012) 0.81
MARS (Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure. Liver (2002) 0.80
A case of portal vein arterialization after a liver transplant. Exp Clin Transplant (2013) 0.80
High preoperative recipient plasma 7beta-hydroxycholesterol is associated with initial poor graft function after liver transplantation. Liver Transpl (2005) 0.79
Transjugular intrahepatic portosystemic shunt for a wait list patient is not a contraindication for orthotopic liver transplant outcomes. Exp Clin Transplant (2013) 0.79
Multislice computed tomography in the preoperative assessment of adult-to-adult living donor liver transplantation: personal results. Radiol Med (2003) 0.78
Ribavirin priming improves the virological response to antiviral treatment in transplanted patients with recurrent hepatitis C: a pilot study. Antivir Ther (2011) 0.77
Ethical considerations on kidney transplantation from living donors. Ann Transplant (2004) 0.76
Cystic presentation of a renal medullary carcinoma in a young woman. Urologia (2014) 0.76
Long-term effect of liver transplantation on cirrhotic autonomic cardiac dysfunction. Dig Liver Dis (2009) 0.76
Parenchymal sparing operations for bronchogenic carcinoma. Surg Clin North Am (2002) 0.76
Recipient perioperative cholesterolaemia and graft cholesterol metabolism gene expression predict liver transplant outcome. Liver Int (2013) 0.76
Failure of hepatitis B vaccination to induce either humoral or cellular immune response after liver transplantation for hepatitis B related cirrhosis. J Hepatol (2005) 0.75
Liver transplant using a severely lacerated graft treated by arterial embolization. Exp Clin Transplant (2013) 0.75
Split-liver transplantation with pediatric donors: a multicenter experience. Transplantation (2005) 0.75
Strategies for evaluation of suitable donors: Italian experience. Ann Transplant (2004) 0.75
TIPS for patients awaiting orthotopic liver transplantation. Liver Transpl (2003) 0.75
A paragastric gossypiboma with caval thrombosis. Ann Vasc Surg (2010) 0.75
Hybrid Partial ALPPS: a Feasible Approach in Case of Right Trisegmentectomy and Macrovascular Invasion. Ann Surg (2017) 0.75
Graft macrosteatosis and time of T-tube removal as risk factors for biliary strictures after liver transplantation. Clin Transplant (2013) 0.75
[Multimodal treatment for acute antibody-mediated renal transplant rejection: successful rescue therapy with combined plasmapheresis, photopheresis and intravenous immunoglobulin]. G Ital Nefrol (2012) 0.75
Portal vein thrombosis before liver transplant does not alter postoperative patient or graft survival. Exp Clin Transplant (2014) 0.75
Which Is the True Role of Bridging Therapies for HCC Patients Waiting for Liver Transplantation? Ann Surg (2017) 0.75
A 3-year experience with Molecular Adsorbent Recirculating System (MARS): our results on 63 patients with hepatic failure and color Doppler US evaluation of cerebral perfusion. Liver Int (2003) 0.75
Chylous Leakage After a Laparoscopic Live-Donor Nephrectomy: Case Report and Literature Review. Exp Clin Transplant (2015) 0.75
Massive bleeding from a gastric varix coil migration in a liver transplant patient. J Gastrointestin Liver Dis (2013) 0.75
Hepatocellular carcinoma (HCC) in non-cirrhotic liver: clinical, radiological and pathological findings. Eur Radiol (2014) 0.75
Bilateral ex vivo repair and kidney autotransplantation for complex renal artery aneurysms: a case report and literature review. Int J Urol (2013) 0.75